Official BRACELET-1 Trial Shows Pelareorep Combined with Paclitaxel Holds Promise in HR+ HER2- Metastatic Breast Cancer
In a groundbreaking development within the field of metastatic breast cancer treatment, the results of the BRACELET-01 (PrECOG 0113) trial ...
